ABT-869, ABT869, Linifanib, AL-39324, RG3635

Catalog Number: SY-ABT-869
Availability: In Stock
Size: 1 mg, 5 mg, 10 mg, 50 mg, 100 mg
CAS Number : 796967-16-3
Alternative Names: ABT-869, ABT869, AL-39324, RG3635

* Size:



ABT-869 (Linifanib) is a potent, selective inhibitor of the VEGF and PDGF platelet-derived growth factor families of RTKs. ABT-869 is being studied in advanced renal cell cancer (RCC), advanced solid tumors, advanced hepatocellular carcinoma (HCC) and non small cell lung cancer (NSCLC).

Compound is also called Linifanib, AL-39324, RG3635

"hcx" and "human proteins, human source" are being used as trade marks by Symansis Pty Ltd   |   © 2014 Symansis Pty Ltd  |   Website by Joe Bunting